PDL falls on Genentech patent letter

PDL BioPharma Inc. (NASDAQ:PDLI) fell $1.02 (16%) to $5.18 on Friday after reporting that it received a letter on Wednesday from Genentech

Read the full 225 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE